RAYMOND JAMES & ASSOCIATES - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 206 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$2,425,651
-23.5%
52,743
-4.4%
0.00%
-33.3%
Q2 2023$3,170,505
+258.8%
55,168
+134.1%
0.00%
+200.0%
Q1 2023$883,538
+36.6%
23,561
+2.1%
0.00%0.0%
Q4 2022$646,646
-11.2%
23,078
-10.9%
0.00%0.0%
Q3 2022$728,000
+14.5%
25,912
+41.7%
0.00%0.0%
Q2 2022$636,000
+6.2%
18,283
+9.5%
0.00%0.0%
Q1 2022$599,000
+117.8%
16,692
+22.1%
0.00%
Q4 2020$275,000
-3.2%
13,666
-9.8%
0.00%
Q3 2020$284,000
-7.5%
15,147
+10.7%
0.00%
Q2 2020$307,000
-62.0%
13,677
-64.2%
0.00%
-100.0%
Q2 2019$807,000
+8.9%
38,231
+5.4%
0.00%0.0%
Q1 2019$741,000
-4.9%
36,287
-7.3%
0.00%0.0%
Q4 2018$779,000
+2.2%
39,160
-1.1%
0.00%0.0%
Q3 2018$762,000
+42.4%
39,612
+13.0%
0.00%0.0%
Q2 2018$535,000
-15.5%
35,049
+3.8%
0.00%0.0%
Q1 2018$633,000
+27.6%
33,752
+31.0%
0.00%0.0%
Q4 2017$496,000
+5.8%
25,763
-1.7%
0.00%0.0%
Q3 2017$469,00026,2180.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2022
NameSharesValueWeighting ↓
Campbell & CO Investment Adviser LLC 11,961$219,0000.13%
FEDERATED HERMES, INC. 3,441,367$63,046,0000.12%
CORNERCAP INVESTMENT COUNSEL INC 54,751$1,003,0000.11%
GSA CAPITAL PARTNERS LLP 34,425$631,0000.10%
First Trust Direct Indexing L.P. 11,913$218,0000.06%
Summit Global Investments 47,546$871,0000.06%
WINTON GROUP Ltd 49,766$912,0000.05%
FULLER & THALER ASSET MANAGEMENT, INC. 397,950$7,290,0000.05%
AIGEN INVESTMENT MANAGEMENT, LP 16,077$295,0000.04%
EXCHANGE TRADED CONCEPTS, LLC 52,334$959,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders